Search Results 321-330 of 17834 for Coagulate

1. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   unless patients are receiving anti-coagulation therapy. Patients receiving anti-coagulation therapy with an agent such warfarin or heparin are allowed to ...

2. A Phase I/II Study Of AZD4512 Monotherapy Or In Combination With Anticancer Agents In Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   ... coagulation indices). Key Exclusion criteria * Patients are excluded if they have a diagnosis of post-transplant lymphoproliferative disease, Richter's ...

3. Atezolizumab Immunotherapy in Patients With Advanced NSCLC (AJCC 7th Edition) - Mayo Clinic

   Hepatic insufficiency resulting in clinical jaundice and/or coagulation defects. Acquired Immune Deficiency Syndrome (AIDS) based upon current CDC ...

4. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

5. A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and G-GSF as Compared to Placebo and G-CSF for thE MobilizatioN of HematopoiEtic Stem Cells for Autologous TransplantatIon in SubjectS With MM - Mayo Clinic

   Coagulation test: INR or PT: ≤ 1.5 x ULN unless subject is receiving anticoagulant therapy, as long as PT or PTT is within therapeutic range of intended ...

6. Detection of Esophageal Cancer by Assay of Novel Methylated DNA Markers in Plasma - Mayo Clinic

   Any endoscopic treatment to current target pathology [Endoscopic intervention examples: Photodynamic therapy, Halo, Cryotherapy, Multi-polar coagulation] ...

7. A Phase 2 Study of CPI-0610 With and Without Ruxolitinib in Patients With Myelofibrosis - Mayo Clinic

   - ECOG performance status ≤ 2. - Adequate hematological, renal, hepatic, and coagulation laboratory assessments - No prior treatment with a BET inhibitor - ...

8. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

   Adequate coagulation parameters within 14 days prior to randomization. International Normalized Ratio (INR) ≤1.5; Activated Prothrombin Time (APTT) ≤ 1.5 x ...

9. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

10. Cytarabine With or Without SCH 900776 in Treating Adult Patients With Relapsed Acute Myeloid Leukemia - Mayo Clinic

    Active disseminated intravascular coagulation (DIC); Active central nervous system (CNS) leukemia; Active, uncontrolled infection; patients with infection ...